It is important to note, however, that the contribution of CD274 expression on non-tumor cells to inhibit the anti-tumor response has at least been questioned[37] and recent studies in pre-clinical lung cancer models also suggested a more dominant role for cancer cell-derived CD274 [38]. This evidence concerns the gene CD274 and lung carcinoma.